Heterozygote carriage of CYP2R1/rs10741657 was associated with a 12% decrease in colorectal cancer risk per 3 μg vitamin D ingested per day (IRR = 0.88, 95% CI: 0.79–0.97). Here, CYP2R1 is linked to colorectal cancer.